Pancreaze — Blue Cross Blue Shield of Oklahoma
off-label indications meeting compendia or peer-reviewed evidence requirements (Ohio Fully Insured or HIM Shop plans)
Initial criteria
- 1. Member resides in Ohio AND
- 2. Plan is Fully Insured or HIM Shop (SG) AND BOTH:
- a. The patient does NOT have any FDA labeled contraindications to the requested agent AND
- b. ONE of the following:
- i. The patient has another FDA labeled indication for the requested agent and route of administration OR
- ii. The patient has another indication supported in compendia for the requested agent and route of administration OR
- iii. The prescriber has submitted TWO peer-reviewed medical journal articles supporting proposed use as safe and effective (randomized, double-blind, placebo-controlled trials; case studies not acceptable)
Approval duration
12 months